Summary

The patient experience technology market is projected to grow from USD 0.74 billion in 2026 to USD 1.29 billion by 2031, at a CAGR of 11.8% during the forecast period. The market is entering a new phase of digital transformation as healthcare providers increasingly adopt technology across the patient journey rather than relying on standalone engagement tools. Growing adoption of AI-powered communication, digital patient portals, virtual care, online appointment scheduling, automated registration, and feedback management is enabling healthcare organizations to improve accessibility, personalization, and patient engagement. Increasing integration of patient experience platforms with EHRs, CRM systems, telehealth platforms, and analytics solutions is further creating opportunities for technology providers. As healthcare organizations place greater emphasis on patient-centric care, convenience, and experience-driven outcomes, demand for scalable and intelligent patient experience solutions is expected to increase substantially over the forecast period.

The cloud-based segment is projected to register high growth among software/platform segments during the forecast period.
Based on the offerings, the patient experience technology market is segmented into software/platform and services. The software/platform is divided into on-premise, cloud-based, and hybrid. The cloud-based platform is expected to see significant market growth during the forecast period due to its scalability, lower upfront costs, and ability to rapidly deploy updates. Healthcare providers increasingly favor cloud solutions for digital check-ins, telehealth triage, patient portals, and AI-driven personalization. Vendors such as Press Ganey, Qualtrics, and Epic are embedding cloud-native analytics, conversational AI, and ambient listening tools that improve flexibility and care access. For instance, in February 2025, Press Ganey partnered with Microsoft to develop generative AI-powered solutions that combine Press Ganey’s dataset of over 7.6 billion patient encounters with Microsoft’s AI, cloud, and ambient listening tools. This collaboration enables predictive analytics for patient safety, real-time actionable insights for providers, and secure data sharing via Azure, demonstrating that cloud-based PX platforms are driving personalization, efficiency, and improved patient experience.

Hence, such strategic collaborations underscore the growing role of cloud-based, AI-enabled patient experience platforms in delivering personalized, efficient, and data-driven care across healthcare settings.

By end user, the healthcare payers segment is expected to grow at the highest CAGR during the forecast period.
By end user, the healthcare payers segment is expected to register the highest CAGR during the forecast period. Payers are increasingly investing in patient experience (PX) platforms to improve member engagement, streamline claims and administrative processes, and enhance overall satisfaction with health plan services. The growing emphasis on value-based care and outcomes-driven reimbursement models is prompting payers to leverage AI, analytics, and patient feedback tools to monitor service quality, predict member needs, and reduce preventable gaps in care.

Digital channels, such as member portals, teletriage, and automated communication tools, are being adopted to provide personalized, real-time support, improve adherence to preventive care, and strengthen patient loyalty. Additionally, regulatory mandates for interoperability and patient access, such as the US Cures Act and Europe’s EHDS, are accelerating payer adoption of patient experience technologies. As a result, payers are emerging as a key growth driver in the market, reflecting their strategic focus on member experience and outcomes.

North America is expected to hold the largest market share.
North America represents the leading regional market, supported by a well-established healthcare IT infrastructure, high adoption of digital health technologies, and a strong presence of leading patient experience technology providers. Healthcare organizations across the region are increasingly investing in digital patient engagement, patient portals, virtual care, automated communication, feedback management, and AI-enabled experience analytics to improve patient satisfaction and operational efficiency. The growing emphasis on patient-centric care, value-based healthcare, interoperability, and consumer-oriented healthcare delivery is further supporting adoption. In addition, continued investments by healthcare providers and technology companies in AI-powered personalization and digital front-door capabilities are strengthening the regional ecosystem. These factors are expected to maintain North America's leading position in the patient experience technology market over the forecast period.

The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation - Directors: 30%, Managers: 34%, and Others: 36%
- By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 5%

Key Players
The key players operating in the patient experience technology market include Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 RCM Inc. (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), and Salesforce, Inc. (US). These companies have adopted strategies such as strategic partnerships, collaborations, product launches, platform enhancements, investments in foundation models and generative AI, mergers and acquisitions, and geographic expansion to strengthen their market presence in the patient experience technology market.

Research Coverage
The report analyzes the patient experience technology market. It estimates the market size and future growth potential of various market segments based on offerings, function, end user, and region. The report also analyzes factors such as drivers, restraints, opportunities, and challenges influencing market growth. It evaluates opportunities across the patient experience technology ecosystem and assesses the competitive landscape for key stakeholders. The report also analyzes micro markets by growth trends, prospects, and contributions to the overall patient experience technology market. It forecasts market revenue across major regions and provides a comprehensive competitive analysis of leading market participants, including their company profiles, product portfolios, recent developments, and key growth strategies.

Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain a greater market share. Firms purchasing the report could use one or more of the following strategies to strengthen their market position.

This report provides insights on:
- Analysis of key drivers (rising demand for digital engagement platforms and personalized patient care, increasing adoption of telehealth, mobile health apps, and AI-powered analytics, government initiatives and funding to accelerate healthcare digital transformation, growing focus on improving patient satisfaction and long-term engagement through real-time feedback tools, and expansion of cloud-based engagement platforms), restraints (data privacy and cybersecurity concerns restricting adoption, high implementation and integration costs for healthcare providers, limited interoperability between patient engagement systems and existing EHRs), opportunities (expansion in emerging markets with growing healthcare infrastructure, adoption of AI-driven personalization and predictive analytics for patient care, rising partnerships with pharma and payers to accelerate digital health adoption, and growing VR/AR platforms for enhanced patient education and adherence), and challenges (ensuring accuracy and reliability of patient feedback data and rapid technological evolution requiring continuous updates and training) influencing the growth of the patient experience technology market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient experience technology market
- Market Development: Comprehensive information on the lucrative emerging markets, by offerings, functions, end user, and region
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient experience technology market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient experience technology market such as Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 RCM Inc. (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), Salesforce, Inc. (US), Vital (US), NexHealth (US), Collectly, Inc. (US), Business Integrity Services (US), and Bamboo Health (US)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 MARKET SCOPE 31
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 31
1.3.2 INCLUSIONS & EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 LIMITATIONS 34
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 35

2 EXECUTIVE SUMMARY 36
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 36
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 38
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 39
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 40
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 41

3 PREMIUM INSIGHTS 42
3.1 PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW 42
3.2 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,
BY OFFERING & REGION 43
3.3 PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 44

4 MARKET OVERVIEW 45
4.1 INTRODUCTION 45
4.2 MARKET DYNAMICS 45
4.2.1 DRIVERS 46
4.2.1.1 Rising demand for digital engagement platforms and personalized patient care 46
4.2.1.2 Increasing adoption of telehealth, mobile health apps, and AI-powered analytics 46
4.2.1.3 Government initiatives and funding for healthcare digital transformation 47
4.2.1.4 Growing focus on improving patient satisfaction and long-term engagement 48
4.2.1.5 Expansion of cloud-based engagement platforms 48
4.2.2 RESTRAINTS 49
4.2.2.1 Data privacy and cybersecurity concerns 49
4.2.2.2 High implementation and integration costs for healthcare providers 50
4.2.2.3 Limited interoperability between patient engagement systems and existing electronic health record systems 50
4.2.3 OPPORTUNITIES 50
4.2.3.1 Growth opportunities in emerging market 50
4.2.3.2 Adoption of AI-driven personalization and predictive analytics for patient care 51
4.2.3.3 Strategic partnerships among technology providers, pharma companies, and payers 51
4.2.3.4 Rising adoption of virtual reality and augmented reality 52
4.2.4 CHALLENGES 52
4.2.4.1 Need to ensure accuracy and reliability of feedback data 52
4.2.4.2 Rapid technological evolution 53
4.3 UNMET NEEDS AND WHITE SPACES 53
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 54
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55

5 INDUSTRY TRENDS 56
5.1 PORTER’S FIVE FORCES ANALYSIS 56
5.2 BARGAINING POWER OF SUPPLIERS 57
5.3 BARGAINING POWER OF BUYERS 57
5.4 THREAT OF NEW ENTRANTS 57
5.5 THREAT OF SUBSTITUTES 58
5.6 INTENSITY OF COMPETITIVE RIVALRY 58
5.7 MACROECONOMIC INDICATORS 58
5.7.1 INTRODUCTION 58
5.7.2 GDP TRENDS AND FORECAST 59
5.7.3 HEALTHCARE DIGITALIZATION AND PATIENT ENGAGEMENT
ADOPTION TRENDS 59
5.8 VALUE CHAIN ANALYSIS 60
5.8.1 PRODUCT DESIGN & DEVELOPMENT 61
5.8.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION 61
5.8.3 IMPLEMENTATION & CHANGE MANAGEMENT 62
5.8.4 EXPERIENCE ANALYTICS & REPORTING INSIGHTS 62
5.8.5 POST-SALES SUPPORT & CONTINUOUS IMPROVEMENT 62
5.9 ECOSYSTEM ANALYSIS 62
5.10 PRICING ANALYSIS 64
5.10.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 64
5.10.2 AVERAGE SELLING PRICE TREND, BY REGION 65
5.11 KEY CONFERENCES AND EVENTS, 2026–2027 66
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67
5.13 INVESTMENT AND FUNDING SCENARIO 68
5.14 CASE STUDY ANALYSIS 69
5.15 IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET 71
5.15.1 INTRODUCTION 71
5.15.2 KEY TARIFF RATES 71
5.15.3 IMPACT ON COUNTRY/REGION 72
5.15.3.1 US 72
5.15.3.2 Europe 72
5.15.3.3 Asia Pacific 72
5.15.4 IMPACT ON END USERS 72
5.15.4.1 Healthcare providers 72
5.15.4.2 Healthcare payers 73
5.15.4.3 Pharma & biotech companies 73
5.15.4.4 Others 73

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 74
6.1 KEY EMERGING TECHNOLOGIES 74
6.1.1 VOICE-OF-THE-PATIENT (VOP) PLATFORMS 74
6.1.2 TELEHEALTH AND VIRTUAL CARE PLATFORMS 74
6.1.3 PATIENT PORTALS AND PERSONAL HEALTH RECORDS 74
6.1.4 REMOTE PATIENT MONITORING (RPM) 75
6.2 COMPLEMENTARY TECHNOLOGIES 75
6.2.1 INTEROPERABILITY/API AND FHIR INFRASTRUCTURE 75
6.2.2 PATIENT IDENTITY MANAGEMENT AND AUTHENTICATION SYSTEMS 75
6.3 ADJACENT TECHNOLOGIES 76
6.3.1 CLINICAL DECISION SUPPORT SYSTEMS (CDSS) 76
6.3.2 POPULATION HEALTH MANAGEMENT (PHM) PLATFORMS 76
6.3.3 PATIENT ENGAGEMENT SOLUTIONS 76
6.4 TECHNOLOGY/PRODUCT ROADMAP 76
6.5 PATENT ANALYSIS 77
6.5.1 PATENT PUBLICATION TRENDS 77
6.5.2 JURISDICTION ANALYSIS 78
6.5.3 MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET 79
6.6 FUTURE APPLICATIONS 81
6.6.1 AI-POWERED DIGITAL FRONT DOOR AND INTELLIGENT PATIENT NAVIGATION 82
6.6.2 PREDICTIVE AND PROACTIVE PATIENT EXPERIENCE MANAGEMENT 82
6.6.3 PERSONALIZED, OMNICHANNEL, AND CONNECTED PATIENT ENGAGEMENT 82

7 REGULATORY LANDSCAPE 83
7.1 REGIONAL REGULATIONS AND COMPLIANCE 83
7.1.1 REGULATORY ANALYSIS 83
7.1.1.1 Regulatory bodies, government agencies, and other organizations 86
7.1.2 INDUSTRY STANDARDS 93

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
8.1 INTRODUCTION 94
8.2 DECISION-MAKING PROCESS 94
8.3 KEY STAKEHOLDERS AND BUYING CRITERIA 95
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 95
8.3.2 KEY BUYING CRITERIA 96
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 97
8.4.1 UNMET NEEDS 98
8.4.2 END-USER EXPECTATIONS 98
8.5 MARKET PROFITABILITY 99

9 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION 100
9.1 INTRODUCTION 101
9.2 APPOINTMENT SCHEDULING 101
9.2.1 ENABLING OPERATIONAL EFFICIENCY AND PATIENT ACCESS 101
9.3 PATIENT REGISTRATION 103
9.3.1 OPTIMIZING FRONT-END WORKFLOWS AND DATA ACCURACY 103
9.4 VIRTUAL CARE 104
9.4.1 EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE 104
9.5 PATIENT COMMUNICATION 106
9.5.1 DRIVING PATIENT ACTIVATION AND CARE ADHERENCE 106
9.6 BILLING 108
9.6.1 PUSH FOR TRANSPARENT & AUTOMATED FINANCIAL WORKFLOWS 108
9.7 FEEDBACK MANAGEMENT 109
9.7.1 FACILITATING CONTINUOUS IMPROVEMENT IN PATIENT EXPERIENCE 109
9.8 OTHER FUNCTIONS 111
9.8.1 GROWING FOCUS ON HOLISTIC, PATIENT-CENTRIC CARE 111

10 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING 112
10.1 INTRODUCTION 113
10.2 SOFTWARE 113
10.2.1 ON-PREMISE SOFTWARE 115
10.2.1.1 Ensuring data control, compliance, and system integration 115
10.2.2 CLOUD-BASED 116
10.2.2.1 Lower upfront costs and seamless interoperability to aid growth 116
10.2.3 HYBRID SOFTWARE 117
10.2.3.1 Ability to ensure maximum compliance and control to boost market 117
10.3 SERVICES 119
10.3.1 MANAGED SERVICES 120
10.3.1.1 Rising demand for operational efficiency and risk mitigation to encourage growth 120
10.3.2 PROFESSIONAL SERVICES 122
10.3.2.1 Need for continuous patient engagement to contribute to growth 122

11 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER 123
11.1 INTRODUCTION 124
11.1.1 HEALTHCARE PROVIDERS 124
11.1.1.1 Growing patient expectations and digital-first strategies 124
11.1.2 HOSPITALS & HEALTH SYSTEMS 126
11.1.2.1 Enterprise-wide digital platforms to unify patient journeys and optimize value-based care 126
11.1.3 OUTPATIENT & AMBULATORY CARE CENTERS 128
11.1.3.1 Digital transformation elevates patient experience in ambulatory settings 128
11.1.4 PHYSICIAN & GROUP PRACTICES 129
11.1.4.1 AI, EHRs, and mobile apps transform care delivery in group practices 129
11.1.5 LONG-TERM CARE & POST-ACUTE FACILITIES 131
11.1.5.1 Enhancing care quality and patient experience in LTC and PAC Facilities 131
11.1.6 OTHER HEALTHCARE PROVIDERS 132
11.1.6.1 Improving patient engagement and care efficiency across specialty and ambulatory settings to drive segment 132
11.2 HEALTHCARE PAYERS 134
11.2.1 ADVANCING MEMBER-CENTRIC CARE TO BOOST GROWTH 134
11.3 PHARMA & BIOTECH COMPANIES 136
11.3.1 PHARMA & BIOTECH ADVANCING PATIENT EXPERIENCE THROUGH DIGITAL SOLUTIONS 136
11.4 OTHER END USERS 137
11.4.1 ENABLERS OF STANDARDS, COMPLIANCE, AND INNOVATION DRIVING PATIENT EXPERIENCE TECHNOLOGY ADOPTION 137

12 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION 139
12.1 INTRODUCTION 140
12.2 NORTH AMERICA 141
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 142
12.2.2 US 145
12.2.2.1 US to dominate global market for patient experience technology 145
12.2.3 CANADA 148
12.2.3.1 Advancing patient-centric digital health solutions 148
12.3 EUROPE 151
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 151
12.3.2 UK 155
12.3.2.1 NHS-driven patient-centric innovation 155
12.3.3 GERMANY 158
12.3.3.1 Digital health leadership and patient engagement 158
12.3.4 FRANCE 161
12.3.4.1 Advancing patient-centric digital health 161
12.3.5 ITALY 164
12.3.5.1 Regional growth and telemedicine expansion 164
12.3.6 SPAIN 167
12.3.6.1 Patient-centric digital health and regional innovation 167
12.3.7 REST OF EUROPE 170
12.4 ASIA PACIFIC 173
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 174
12.4.2 JAPAN 178
12.4.2.1 Rapidly growing elderly population to propel market expansion 178
12.4.3 CHINA 181
12.4.3.1 Widespread super-app integration to accelerate adoption 181
12.4.4 INDIA 184
12.4.4.1 National digital health programs accelerating market growth in India 184
12.4.5 SOUTH KOREA 187
12.4.5.1 Regulatory liberalization and ICT integration fueling market growth 187
12.4.6 AUSTRALIA 190
12.4.6.1 Mature healthcare system and digital infrastructure driving adoption 190
12.4.7 REST OF ASIA PACIFIC 193
12.5 LATIN AMERICA 196
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 197
12.5.2 BRAZIL 200
12.5.2.1 Brazil to dominate patient experience technology market in Latin America 200
12.5.3 MEXICO 203
12.5.3.1 Mexico emerges as a hub for retail-integrated and multilingual patient experience platforms 203
12.5.4 REST OF LATIN AMERICA 206
12.6 MIDDLE EAST & AFRICA 209
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 209
12.6.2 GCC COUNTRIES 213
12.6.2.1 Rising healthcare investments to fuel uptake 213
12.6.2.2 Saudi Arabia 216
12.6.2.2.1 Vision 2030 and MoH digital-first strategy 216
12.6.2.3 UAE 219
12.6.2.3.1 Government-led digital transformation and private-sector innovation 219
12.6.2.4 Rest of GCC 222
12.6.2.4.1 Rising demand for telehealth & virtual care 222
12.6.3 SOUTH AFRICA 225
12.6.4 REST OF MIDDLE EAST & AFRICA 228

13 COMPETITIVE LANDSCAPE 232
13.1 OVERVIEW 232
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 232
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET 233
13.3 REVENUE ANALYSIS, 2021–2025 235
13.4 MARKET SHARE ANALYSIS, 2025 236
13.5 COMPANY VALUATION AND FINANCIAL METRICS 239
13.6 BRAND/SOFTWARE COMPARISON 240
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 241
13.7.1 STARS 241
13.7.2 EMERGING LEADERS 241
13.7.3 PERVASIVE PLAYERS 241
13.7.4 PARTICIPANTS 241
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 243
13.7.5.1 Company footprint 243
13.7.5.2 Region footprint 244
13.7.5.3 Offering footprint 245
13.7.5.4 Function footprint 246
13.7.5.5 End user footprint 247
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 248
13.8.1 PROGRESSIVE COMPANIES 248
13.8.2 RESPONSIVE COMPANIES 248
13.8.3 DYNAMIC COMPANIES 248
13.8.4 STARTING BLOCKS 248
13.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 250
13.8.5.1 Detailed list of key startups/SMEs 250
13.8.5.2 Competitive benchmarking of key startups/SMEs 251
13.9 COMPETITIVE SCENARIO 252
13.9.1 SOLUTION/SERVICE LAUNCHES 252
13.9.2 DEALS 253
13.9.3 EXPANSIONS 255

14 COMPANY PROFILES 257
14.1 KEY PLAYERS 257
14.1.1 PRESS GANEY 257
14.1.1.1 Business overview 257
14.1.1.2 Solutions offered 258
14.1.1.3 Recent developments 258
14.1.1.3.1 Solution launches and enhancements 258
14.1.1.3.2 Deals 259
14.1.1.4 MnM view 260
14.1.1.4.1 Right to win 260
14.1.1.4.2 Strategic choices 260
14.1.1.4.3 Weaknesses and competitive threats 260
14.1.2 NATIONAL RESEARCH CORPORATION 261
14.1.2.1 Business overview 261
14.1.2.2 Solutions offered 262
14.1.2.3 Recent developments 262
14.1.2.3.1 Solution launches and enhancements 262
14.1.2.4 MnM view 263
14.1.2.4.1 Right to win 263
14.1.2.4.2 Strategic choices 263
14.1.2.4.3 Weaknesses and competitive threats 263
14.1.3 MEDALLIA INC. 264
14.1.3.1 Business overview 264
14.1.3.2 Solutions offered 264
14.1.3.3 Recent developments 265
14.1.3.3.1 Solution launches and enhancements 265
14.1.3.3.2 Deals 266
14.1.3.4 MnM view 266
14.1.3.4.1 Right to win 266
14.1.3.4.2 Strategic choices 266
14.1.3.4.3 Weaknesses and competitive threats 267
14.1.4 PHREESIA 268
14.1.4.1 Business overview 268
14.1.4.2 Products offered 269
14.1.4.3 Recent developments 270
14.1.4.3.1 Solution launches and enhancements 270
14.1.4.3.2 Deals 270
14.1.4.4 MnM view 271
14.1.4.4.1 Right to win 271
14.1.4.4.2 Strategic choices 271
14.1.4.4.3 Weaknesses and competitive threats 271
14.1.5 NICE 272
14.1.5.1 Business overview 272
14.1.5.2 Solutions offered 273
14.1.5.3 MnM view 274
14.1.5.3.1 Right to win 274
14.1.5.3.2 Strategic choices 274
14.1.5.3.3 Weaknesses and competitive threats 274
14.1.6 R1 275
14.1.6.1 Business overview 275
14.1.6.2 Solutions offered 275
14.1.6.3 Recent developments 276
14.1.6.3.1 Solution launches and enhancements 276
14.1.6.3.2 Deals 277
14.1.7 EPIC SYSTEMS CORPORATION 278
14.1.7.1 Business overview 278
14.1.7.2 Solutions offered 278
14.1.7.3 Recent developments 279
14.1.7.3.1 Solution launches and enhancements 279
14.1.7.3.2 Deals 280
14.1.8 IQVIA 281
14.1.8.1 Business overview 281
14.1.8.2 Solutions offered 283
14.1.8.3 Recent developments 283
14.1.8.3.1 Solution launches and enhancements 283
14.1.9 QUALTRICS 284
14.1.9.1 Business overview 284
14.1.9.2 Solutions offered 285
14.1.9.3 Recent developments 285
14.1.9.3.1 Deals 285
14.1.9.3.2 Expansions 286
14.1.9.3.3 Other developments 287
14.1.10 RELIAS LLC 288
14.1.10.1 Business overview 288
14.1.10.2 Solutions offered 288
14.1.10.3 Recent developments 289
14.1.10.3.1 Deals 289
14.1.11 GETWELLNETWORK, INC. 290
14.1.11.1 Business overview 290
14.1.11.2 Solutions offered 290
14.1.11.3 Recent developments 291
14.1.11.3.1 Solution launches and enhancements 291
14.1.11.3.2 Deals 291
14.1.12 CIPHERHEALTH INC. 292
14.1.12.1 Business overview 292
14.1.12.2 Solutions offered 292
14.1.12.3 Recent developments 293
14.1.12.3.1 Solution launches and enhancements 293
14.1.12.3.2 Deals 293
14.1.13 KYRUUS, INC. 294
14.1.13.1 Business overview 294
14.1.13.2 Solutions offered 294
14.1.13.3 Recent developments 295
14.1.13.3.1 Solution launches and enhancements 295
14.1.13.3.2 Deals 296
14.1.14 RELATIENT 297
14.1.14.1 Business overview 297
14.1.14.2 Solutions offered 297
14.1.14.3 Recent developments 298
14.1.14.3.1 Solution launches and enhancements 298
14.1.15 ALIDA 299
14.1.15.1 Business overview 299
14.1.15.2 Solutions offered 299
14.1.16 TWILIO INC. 300
14.1.16.1 Business overview 300
14.1.16.2 Solutions offered 302
14.1.16.3 Recent developments 302
14.1.16.3.1 Solution launches and enhancements 302
14.1.16.3.2 Deals 303
14.1.17 AVAAMO 304
14.1.17.1 Business overview 304
14.1.17.2 Products offered 304
14.1.17.3 Recent developments 305
14.1.17.3.1 Solution launches and enhancements 305
14.1.18 CERTIFY HEALTH 306
14.1.18.1 Business overview 306
14.1.18.2 Solutions offered 306
14.1.18.3 Recent developments 307
14.1.18.3.1 Other developments 307
14.1.19 LUMA HEALTH INC. 308
14.1.19.1 Business overview 308
14.1.19.2 Solutions offered 308
14.1.19.3 Recent developments 309
14.1.19.3.1 Solution launches and enhancements 309
14.1.19.3.2 Deals 309
14.1.20 SOLUTIONREACH 310
14.1.20.1 Business overview 310
14.1.20.2 Solutions offered 310
14.1.20.3 Recent developments 311
14.1.20.3.1 Solution launches and enhancements 311
14.1.21 SALESFORCE, INC. 312
14.1.21.1 Business overview 312
14.1.21.2 Solutions offered 314
14.1.21.3 Recent developments 315
14.1.21.3.1 Solution launches and enhancements 315
14.2 OTHER PLAYERS 317
14.2.1 VITAL 317
14.2.2 NEXHEALTH 318
14.2.3 COLLECTLY, INC. 319
14.2.4 BUSINESS INTEGRITY SERVICES 320
14.2.5 BAMBOO HEALTH 321

15 RESEARCH METHODOLOGY 322
15.1 RESEARCH DATA 322
15.1.1 SECONDARY DATA 323
15.1.1.1 Key data from secondary sources 323
15.1.2 PRIMARY DATA 324
15.1.2.1 Key data from primary sources 325
15.1.2.2 Breakdown of primary sources 326
15.2 RESEARCH METHODOLOGY DESIGN 327
15.3 MARKET SIZE ESTIMATION 328
15.4 MARKET BREAKDOWN & DATA TRIANGULATION 334
15.5 RESEARCH ASSUMPTIONS 335
15.5.1 MARKET SIZING ASSUMPTIONS 335
15.5.2 OVERALL STUDY ASSUMPTIONS 336
15.6 RISK ASSESSMENT 336
15.7 RESEARCH LIMITATIONS 337
15.7.1 METHODOLOGY-RELATED LIMITATIONS 337
15.7.2 SCOPE-RELATED LIMITATIONS 337

16 APPENDIX 338
16.1 DISCUSSION GUIDE 338
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 342
16.3 CUSTOMIZATION OPTIONS 344
16.4 RELATED REPORTS 345
16.5 AUTHOR DETAILS 346

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 PATIENT EXPERIENCE TECHNOLOGY MARKET SEGMENTATION & REGIONAL SCOPE 31.
FIGURE 2 MARKET SCENARIO 37.
FIGURE 3 GLOBAL PATIENT EXPERIENCE TECHNOLOGY MARKET, 2024–2031 37.
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2023–2026 38.
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF PATIENT.
EXPERIENCE TECHNOLOGY MARKET 39.
FIGURE 6 HIGH-GROWTH SEGMENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2026–2031 40.
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PATIENT EXPERIENCE.
TECHNOLOGY MARKET DURING FORECAST PERIOD 41.
FIGURE 8 INCREASING ADOPTION OF DIGITAL HEALTH SOLUTIONS.
TO ENHANCE PATIENT ENGAGEMENT 42.
FIGURE 9 SOFTWARE/PLATFORMS IN NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 43.
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 44.
FIGURE 11 PATIENT EXPERIENCE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45.
FIGURE 12 PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 56.
FIGURE 13 PATIENT EXPERIENCE TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS 61.
FIGURE 14 PATIENT EXPERIENCE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 63.
FIGURE 15 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY,.
BY REGION, 2022–2025 (USD) 66.
FIGURE 16 PATIENT EXPERIENCE TECHNOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 68.
FIGURE 17 RECENT FUNDING ACTIVITY IN PATIENT EXPERIENCE TECHNOLOGY MARKET 68.
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN PATIENT EXPERIENCE TECHNOLOGY, 2015–2026 77.
FIGURE 19 JURISDICTION ANALYSIS OF PATIENT EXPERIENCE TECHNOLOGY PATENTS, JANUARY 2015–SEPTEMBER 2026 78.
FIGURE 20 PATIENT EXPERIENCE TECHNOLOGY MARKET: PATENT ANALYSIS,.
JANUARY 2015–SEPTEMBER 2026 79.
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 95.
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 96.
FIGURE 23 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT 141.
FIGURE 24 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT 174.
FIGURE 25 PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ANALYSIS OF.
KEY PLAYERS, 2021–2025 (USD MILLION) 236.
FIGURE 26 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2025 237.
FIGURE 27 EV/EBITDA OF KEY VENDORS 239.
FIGURE 28 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK.
BETA OF KEY VENDORS 239.
FIGURE 29 PATIENT EXPERIENCE TECHNOLOGY MARKET: BRAND/SOFTWARE COMPARISON 240.
FIGURE 30 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 242.
FIGURE 31 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY FOOTPRINT 243.
FIGURE 32 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 249.
FIGURE 33 NATIONAL RESEARCH CORPORATION: COMPANY SNAPSHOT (2025) 261.
FIGURE 34 PHREESIA: COMPANY SNAPSHOT (2025) 269.
FIGURE 35 NICE: COMPANY SNAPSHOT (2025) 273.
FIGURE 36 IQVIA: COMPANY SNAPSHOT (2025) 282.
FIGURE 37 TWILIO INC.: COMPANY SNAPSHOT (2025) 301.
FIGURE 38 SALESFORCE, INC.: COMPANY SNAPSHOT (2025) 313.
FIGURE 39 RESEARCH DESIGN 322.
FIGURE 40 PRIMARY SOURCES 324.
FIGURE 41 INSIGHTS FROM INDUSTRY EXPERTS 326.
FIGURE 42 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,.
DESIGNATION, AND REGION 326.
FIGURE 43 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 327.
FIGURE 44 SUPPLY-SIDE MARKET ESTIMATION 329.
FIGURE 45 PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ESTIMATION APPROACH 329.
FIGURE 46 BOTTOM-UP APPROACH 331.
FIGURE 47 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 333.
FIGURE 48 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 333.
FIGURE 49 TOP-DOWN APPROACH 334.
FIGURE 50 DATA TRIANGULATION METHODOLOGY 335.
TABLE 1 USD EXCHANGE RATES 33.
TABLE 2 PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 57.
TABLE 3 PATIENT EXPERIENCE TECHNOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 63.
TABLE 4 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE SOFTWARE,.
BY KEY PLAYER, 2022–2025 (USD) 65.
TABLE 5 AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY,.
BY REGION, 2022–2025 (USD) 66.
TABLE 6 PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 67.
TABLE 7 CASE STUDY 1: IMPROVED PATIENT-CENTERED CARE WITH DIGIVALET PATIENT EXPERIENCE PLATFORM 69.
TABLE 8 CASE STUDY 2: PAPERLESS ADMISSIONS VIA PWC + SALESFORCE DIGITAL PATIENT PORTAL 69.
TABLE 9 CASE STUDY 3: TIMELY PATIENT COMMUNICATIONS WITH TWILIO MESSAGING 70.
TABLE 10 CASE STUDY 4: DIGITAL WAYFINDING & WI-FI ENHANCEMENTS BY WORLDWIDE TECHNOLOGY 70.
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES 71.
TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT EXPERIENCE TECHNOLOGY 78.
TABLE 13 PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY PATENTS/PATENT APPLICATIONS 80.
TABLE 14 REGULATORY SCENARIO IN NORTH AMERICA 83.
TABLE 15 REGULATORY SCENARIO IN EUROPE 84.
TABLE 16 REGULATORY SCENARIO IN ASIA PACIFIC 85.
TABLE 17 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 85.
TABLE 18 REGULATORY SCENARIO IN LATIN AMERICA 86.
TABLE 19 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86.
TABLE 20 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89.
TABLE 21 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90.
TABLE 22 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91.
TABLE 23 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92.
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF.
TOP THREE END USERS (%) 96.
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 97.
TABLE 26 PATIENT EXPERIENCE TECHNOLOGY MARKET: UNMET NEEDS 98.
TABLE 27 PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER EXPECTATIONS 98.
TABLE 28 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 101.
TABLE 29 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR APPOINTMENT SCHEDULING,.
BY COUNTRY, 2024–2031 (USD MILLION) 102.
TABLE 30 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT REGISTRATION,.
BY COUNTRY, 2024–2031 (USD MILLION) 104.
TABLE 31 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR VIRTUAL CARE, BY COUNTRY, 2024–2031 (USD MILLION) 105.
TABLE 32 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT COMMUNICATION,.
BY COUNTRY, 2024–2031 (USD MILLION) 107.
TABLE 33 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR BILLING, BY COUNTRY,.
2024–2031 (USD MILLION) 109.
TABLE 34 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR FEEDBACK MANAGEMENT,.
BY COUNTRY, 2024–2031 (USD MILLION) 110.
TABLE 35 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER FUNCTIONS,.
BY COUNTRY, 2024–2031 (USD MILLION) 111.
TABLE 36 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 113.
TABLE 37 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,.
BY DEPLOYMENT, 2024–2031 (USD MILLION) 114.
TABLE 38 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE,.
BY COUNTRY, 2024–2031 (USD MILLION) 114.
TABLE 39 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR ON-PREMISE SOFTWARE,.
BY COUNTRY, 2024–2031 (USD MILLION) 115.
TABLE 40 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR CLOUD-BASED SOFTWARE,.
BY REGION, 2024–2031 (USD MILLION) 117.
TABLE 41 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HYBRID SOFTWARE,.
BY COUNTRY, 2024–2031 (USD MILLION) 118.
TABLE 42 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY SERVICE,.
2024–2031 (USD MILLION) 119.
TABLE 43 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY COUNTRY,.
2024–2031 (USD MILLION) 120.
TABLE 44 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR MANAGED SERVICES,.
BY COUNTRY, 2024–2031 (USD MILLION) 121.
TABLE 45 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PROFESSIONAL SERVICES,.
BY COUNTRY, 2024–2031 (USD MILLION) 122.
TABLE 46 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 124.
TABLE 47 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS,.
BY TYPE, 2024–2031 (USD MILLION) 125.
TABLE 48 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS,.
BY COUNTRY, 2024–2031 (USD MILLION) 126.
TABLE 49 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 127.
TABLE 50 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 129.
TABLE 51 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHYSICIAN & GROUP PRACTICES, BY COUNTRY, 2024–2031 (USD MILLION) 130.
TABLE 52 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION) 132.
TABLE 53 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION) 133.
TABLE 54 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PAYERS,.
BY COUNTRY, 2024–2031 (USD MILLION) 135.
TABLE 55 PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 136.
TABLE 56 PATIENT EXPERIENCE TECHNOLOGY FOR OTHER END USERS,.
BY COUNTRY, 2024–2031 (USD MILLION) 138.
TABLE 57 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION,.
2024–2031 (USD MILLION) 140.
TABLE 58 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 142.
TABLE 59 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 142.
TABLE 60 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 143.
TABLE 61 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 143.
TABLE 62 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 144.
TABLE 63 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 144.
TABLE 64 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 145.
TABLE 65 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 146.
TABLE 66 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM,.
BY TYPE, 2024–2031 (USD MILLION) 146.
TABLE 67 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE,.
2024–2031 (USD MILLION) 146.
TABLE 68 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 147.
TABLE 69 US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 147.
TABLE 70 US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 148.
TABLE 71 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 149.
TABLE 72 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 149.
TABLE 73 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 149.
TABLE 74 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 150.
TABLE 75 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 150.
TABLE 76 CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 151.
TABLE 77 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 152.
TABLE 78 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 152.
TABLE 79 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 153.
TABLE 80 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 153.
TABLE 81 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 154.
TABLE 82 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 154.
TABLE 83 EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 155.
TABLE 84 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 156.
TABLE 85 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM,.
BY TYPE, 2024–2031 (USD MILLION) 156.
TABLE 86 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE,.
2024–2031 (USD MILLION) 156.
TABLE 87 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 157.
TABLE 88 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 157.
TABLE 89 UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 158.
TABLE 90 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 159.
TABLE 91 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 159.
TABLE 92 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 159.
TABLE 93 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 160.
TABLE 94 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 160.
TABLE 95 GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 161.
TABLE 96 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 162.
TABLE 97 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 162.
TABLE 98 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 162.
TABLE 99 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 163.
TABLE 100 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 163.
TABLE 101 FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 164.
TABLE 102 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 165.
TABLE 103 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 104 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 165.
TABLE 105 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 166.
TABLE 106 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 166.
TABLE 107 ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 167.
TABLE 108 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 168.
TABLE 109 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 168.
TABLE 110 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 168.
TABLE 111 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 169.
TABLE 112 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 169.
TABLE 113 SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 170.
TABLE 114 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 171.
TABLE 115 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 116 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 171.
TABLE 117 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 172.
TABLE 118 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 172.
TABLE 119 REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 173.
TABLE 120 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY,.
2024–2031 (USD MILLION) 175.
TABLE 121 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 175.
TABLE 122 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 176.
TABLE 123 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 176.
TABLE 124 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 177.
TABLE 125 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 177.
TABLE 126 ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 178.
TABLE 127 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 179.
TABLE 128 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 179.
TABLE 129 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 179.
TABLE 130 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 180.
TABLE 131 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 180.
TABLE 132 JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 181.
TABLE 133 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 182.
TABLE 134 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 182.
TABLE 135 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 182.
TABLE 136 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 183.
TABLE 137 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 183.
TABLE 138 CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 184.
TABLE 139 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 185.
TABLE 140 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 141 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 185.
TABLE 142 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 186.
TABLE 143 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 186.
TABLE 144 INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 187.
TABLE 145 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 188.
TABLE 146 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 188.
TABLE 147 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 188.
TABLE 148 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 189.
TABLE 149 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 189.
TABLE 150 SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 190.
TABLE 151 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 191.
TABLE 152 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 191.
TABLE 153 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 191.
TABLE 154 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 192.
TABLE 155 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 192.
TABLE 156 AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 193.
TABLE 157 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 194.
TABLE 158 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 159 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 194.
TABLE 160 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 195.
TABLE 161 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY END USER, 2024–2031 (USD MILLION) 195.
TABLE 162 REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 196.
TABLE 163 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 197.
TABLE 164 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 197.
TABLE 165 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 166 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 198.
TABLE 167 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 199.
TABLE 168 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 199.
TABLE 169 LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 200.
TABLE 170 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 201.
TABLE 171 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 201.
TABLE 172 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 201.
TABLE 173 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 202.
TABLE 174 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 202.
TABLE 175 BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 203.
TABLE 176 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 204.
TABLE 177 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 204.
TABLE 178 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 204.
TABLE 179 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 205.
TABLE 180 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 205.
TABLE 181 MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 206.
TABLE 182 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 207.
TABLE 183 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 184 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 207.
TABLE 185 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 208.
TABLE 186 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY END USER, 2024–2031 (USD MILLION) 208.
TABLE 187 REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 209.
TABLE 188 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY COUNTRY, 2024–2031 (USD MILLION) 210.
TABLE 189 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 210.
TABLE 190 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 191 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 211.
TABLE 192 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 212.
TABLE 193 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY END USER, 2024–2031 (USD MILLION) 212.
TABLE 194 MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 213.
TABLE 195 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 214.
TABLE 196 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET.
FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 214.
TABLE 197 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 214.
TABLE 198 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 215.
TABLE 199 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 215.
TABLE 200 GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 216.
TABLE 201 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 217.
TABLE 202 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 203 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 217.
TABLE 204 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 218.
TABLE 205 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 218.
TABLE 206 SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 219.
TABLE 207 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 220.
TABLE 208 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM,.
BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 209 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 220.
TABLE 210 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 221.
TABLE 211 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 221.
TABLE 212 UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 222.
TABLE 213 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING,.
2024–2031 (USD MILLION) 223.
TABLE 214 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 215 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 223.
TABLE 216 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION,.
2024–2031 (USD MILLION) 224.
TABLE 217 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER,.
2024–2031 (USD MILLION) 224.
TABLE 218 REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 225.
TABLE 219 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 226.
TABLE 220 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 226.
TABLE 221 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES,.
BY TYPE, 2024–2031 (USD MILLION) 226.
TABLE 222 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 227.
TABLE 223 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 227.
TABLE 224 SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 228.
TABLE 225 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY OFFERING, 2024–2031 (USD MILLION) 229.
TABLE 226 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION) 229.
TABLE 227 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION) 229.
TABLE 228 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY FUNCTION, 2024–2031 (USD MILLION) 230.
TABLE 229 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET,.
BY END USER, 2024–2031 (USD MILLION) 230.
TABLE 230 REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 231.
TABLE 231 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, JANUARY 2023–JULY 2026 233.
TABLE 232 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEGREE OF COMPETITION 237.
TABLE 233 PATIENT EXPERIENCE TECHNOLOGY MARKET: REGION FOOTPRINT 244.
TABLE 234 PATIENT EXPERIENCE TECHNOLOGY MARKET: OFFERING FOOTPRINT 245.
TABLE 235 PATIENT EXPERIENCE TECHNOLOGY MARKET: FUNCTION FOOTPRINT 246.
TABLE 236 PATIENT EXPERIENCE TECHNOLOGY MARKET: END USER FOOTPRINT 247.
TABLE 237 PATIENT EXPERIENCE TECHNOLOGY MARKET: DETAILED LIST.
OF KEY STARTUPS/SMES 250.
TABLE 238 PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPETITIVE.
BENCHMARKING OF KEY STARTUPS/SMES 251.
TABLE 239 PATIENT EXPERIENCE TECHNOLOGY MARKET: SOLUTION/SERVICE.
LAUNCHES, JANUARY 2023–JULY 2026 252.
TABLE 240 PATIENT EXPERIENCE TECHNOLOGY MARKET: DEALS, JANUARY 2023 - JULY 2026 253.
TABLE 241 PATIENT EXPERIENCE TECHNOLOGY MARKET: EXPANSIONS,.
JANUARY 2023 - JULY 2026 255.
TABLE 242 PRESS GANEY: COMPANY OVERVIEW 257.
TABLE 243 PRESS GANEY: SOLUTIONS OFFERED 258.
TABLE 244 PRESS GANEY: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 258.
TABLE 245 PRESS GANEY: DEALS, JANUARY 2023–JULY 2026 259.
TABLE 246 NATIONAL RESEARCH CORPORATION: COMPANY OVERVIEW 261.
TABLE 247 NATIONAL RESEARCH CORPORATION: SOLUTIONS OFFERED 262.
TABLE 248 NATIONAL RESEARCH CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 262.
TABLE 249 MEDALLIA INC.: COMPANY OVERVIEW 264.
TABLE 250 MEDALLIA INC.: SOLUTIONS OFFERED 264.
TABLE 251 MEDALLIA INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 265.
TABLE 252 MEDALLIA INC.: DEALS, JANUARY 2023–JULY 2026 266.
TABLE 253 PHREESIA: COMPANY OVERVIEW 268.
TABLE 254 PHREESIA: SOLUTIONS OFFERED 269.
TABLE 255 PHREESIA: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 270.
TABLE 256 PHREESIA: DEALS, JANUARY 2023–JULY 2026 270.
TABLE 257 NICE: COMPANY OVERVIEW 272.
TABLE 258 NICE: SOLUTIONS OFFERED 273.
TABLE 259 R1: COMPANY OVERVIEW 275.
TABLE 260 R1: SOLUTIONS OFFERED 275.
TABLE 261 R1 RCM INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 276.
TABLE 262 R1: DEALS, JANUARY 2023–JULY 2026 277.
TABLE 263 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 278.
TABLE 264 EPIC SYSTEMS CORPORATION: SOLUTIONS OFFERED 278.
TABLE 265 EPIC SYSTEMS CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 279.
TABLE 266 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023–JULY 2026 280.
TABLE 267 IQVIA: COMPANY OVERVIEW 281.
TABLE 268 IQVIA: SOLUTIONS OFFERED 283.
TABLE 269 IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 283.
TABLE 270 QUALTRICS: COMPANY OVERVIEW 284.
TABLE 271 QUALTRICS: SOLUTIONS OFFERED 285.
TABLE 272 QUALTRICS: DEALS, JANUARY 2023–JULY 2026 285.
TABLE 273 QUALTRICS: EXPANSIONS, JANUARY 2023–JULY 2026 286.
TABLE 274 QUALTRICS: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 287.
TABLE 275 RELIAS LLC: COMPANY OVERVIEW 288.
TABLE 276 RELIAS LLC: SOLUTIONS OFFERED 288.
TABLE 277 RELIAS LLC: DEALS, JANUARY 2023–JULY 2026 289.
TABLE 278 GETWELLNETWORK, INC.: COMPANY OVERVIEW 290.
TABLE 279 GETWELLNETWORK, INC.: SOLUTIONS OFFERED 290.
TABLE 280 GETWELLNETWORK, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 291.
TABLE 281 GETWELLNETWORK, INC.: DEALS, JANUARY 2023–JULY 2026 291.
TABLE 282 CIPHERHEALTH INC.: COMPANY OVERVIEW 292.
TABLE 283 CIPHERHEALTH INC.: SOLUTIONS OFFERED 292.
TABLE 284 CIPHERHEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 293.
TABLE 285 CIPHERHEALTH INC.: DEALS, JANUARY 2023–JULY 2026 293.
TABLE 286 KYRUUS, INC.: COMPANY OVERVIEW 294.
TABLE 287 KYRUUS, INC.: SOLUTIONS OFFERED 294.
TABLE 288 KYRUUS, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 295.
TABLE 289 KYRUUS, INC.: DEALS, JANUARY 2023–JULY 2026 296.
TABLE 290 RELATIENT: COMPANY OVERVIEW 297.
TABLE 291 RELATIENT: SOLUTIONS OFFERED 297.
TABLE 292 RELATIENT: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 298.
TABLE 293 ALIDA: COMPANY OVERVIEW 299.
TABLE 294 ALIDA: SOLUTIONS OFFERED 299.
TABLE 295 TWILIO INC.: COMPANY OVERVIEW 300.
TABLE 296 TWILIO INC.: SOLUTIONS OFFERED 302.
TABLE 297 TWILIO INC.: SOLUTION LAUNCHES AND ENHANCEMENTS,.
JANUARY 2023–JULY 2026 302.
TABLE 298 TWILIO INC.: DEALS, JANUARY 2023–JULY 2026 303.
TABLE 299 AVAAMO: COMPANY OVERVIEW 304.
TABLE 300 AVAAMO: SOLUTIONS OFFERED 304.
TABLE 301 AVAAMO: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026 305.
TABLE 302 CERTIFY HEALTH: COMPANY OVERVIEW 306.
TABLE 303 CERTIFY HEALTH: SOLUTIONS OFFERED 306.
TABLE 304 CERTIFY HEALTH: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 307.
TABLE 305 LUMA HEALTH INC.: COMPANY OVERVIEW 308.